SC
Swati Chandrakant Sawant
About Swati Chandrakant Sawant
Data last updated:
Swati Chandrakant Sawant is a Director at Suepravision Life Sciences Private Limited (since 2012) and Director at Dgmax Financial Advisory Private Limited (since 2022). The companies operate in Business Services and Financial Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Dec 2012 | 2012 | Active | ||
| Director | 14 Mar 2022 | 2022 | Under Process Of Striking Off |
Board colleagues of Swati Chandrakant Sawant
| Name | DIN | Company | Designation |
|---|---|---|---|
| Audumbar Vithal Sawant | 06403753 | Suepravision Life Sciences Private Limited | Director |
| Chandrakant Vithal Sawant | 06402977 | Suepravision Life Sciences Private Limited , Dgmax Financial Advisory Private Limited | Director |
| Vidya Audumbar Sawant | 06403088 | Suepravision Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swati Chandrakant Sawant
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swati Chandrakant Sawant
Swati Chandrakant Sawant currently holds 2 directorships: Suepravision Life Sciences Private Limited (Director, since 10 Dec 2012); Dgmax Financial Advisory Private Limited (Director, since 14 Mar 2022).
Swati Chandrakant Sawant was first appointed on 10 Dec 2012 as Director at Suepravision Life Sciences Private Limited. The most recent appointment on record is 14 Mar 2022 at Dgmax Financial Advisory Private Limited.
The current boards of Swati Chandrakant Sawant's companies include Audumbar Vithal Sawant (Suepravision Life Sciences Private Limited), Chandrakant Vithal Sawant (Suepravision Life Sciences Private Limited), Vidya Audumbar Sawant (Suepravision Life Sciences Private Limited).